
Dr Kline discusses longer-term efficacy data from the FIREFLY-1 study of tovorafenib in patients with relapsed/refractory pediatric low-grade glioma.

Your AI-Trained Oncology Knowledge Connection!

Cassie Kline, MD, MAS, is an attending physician and director of clinical research in the department of Neuro-Oncology at Children's Hospital of Philadelphia.

Dr Kline discusses longer-term efficacy data from the FIREFLY-1 study of tovorafenib in patients with relapsed/refractory pediatric low-grade glioma.

Cassie Kline, MD, MAS, discusses 3-year follow-up data with tovorafenib in patients with pediatric low-grade glioma from FIREFLY-1.